Resurrecting the resurrection drug.
Potter
P
Wickware
D000349:Africa / Q000453:epidemiology; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003906:Developing Countries; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D000518:Eflornithine / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D008019:Life Style; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000188:drug therapy / Q000453:epidemiology; D014944:World Health Organization
D000970:Antineoplastic Agents; D014344:Trypanocidal Agents; D000518:Eflornithine